TCA Cellular Therapy

For profit

Also known as: TCA Cellular Therapy, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jun 1, 2007

Last known activity

Jul 1, 2010

Defunct as of Aug 8, 2011

Timeline

2000s

Jun 1, 2004
TCA Cellular Therapy— Founded

2010s

Aug 8, 2011
TCA Cellular Therapy— Defunct

Drugs by trial phase (2 distinct, 7 trials)

Phase 2 (1 own, 0 via acquisition)

bone marrow derived mesenchymal stem cells

Phase 1 (1 own, 0 via acquisition)

allogeneic adipose derived mesenchymal stem cell

Indications

Studied for

Recent trials (11)

NCT01162915Lead sponsorPhase 1Jul 1, 2010
NCT01082653Lead sponsorPhase 1Mar 1, 2010
NCT00790764Overall official - principal investigatorPhase 2Nov 1, 2008
NCT00790764Lead sponsorPhase 2Nov 1, 2008
NCT00721006Overall official - principal investigatorPhase 2Jun 1, 2008
NCT00721006Lead sponsorPhase 2Jun 1, 2008
NCT00643981Lead sponsorPhase 1Feb 1, 2008
NCT00548613Overall official - principal investigatorPhase 1Oct 1, 2007
NCT00548613Lead sponsorPhase 1Oct 1, 2007
NCT00518401Lead sponsorPhase 1Jun 1, 2007
NCT00518401Overall official - principal investigatorPhase 1Jun 1, 2007

Details

Founded: Covington, LA, US Jun 1, 2004
Last known activity: Jul 1, 2010

Notes

No evidence of activity beyond FDA warning letter https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=2ahUKEwi4upaZvIziAhUHOq0KHX4dAiQQFjAEegQICBAC&url=http%3A%2F%2Fwww.circare.org%2Ffdawls2%2Ftcacelluar_fdawl_20110811.pdf&usg=AOvVaw1q0aPVZXqG425xfeI1vmlF